cagrilintide semaglutide combination trial weight loss 2024 VisualAbstract: Combined and for management well-tolerated in early clinical trials Presenters to provide first look
Presenters to provide first look at data from REIMAGINE trials of cagrilintide semaglutide for type 2 diabetes management ADA Meeting News Cagrilintide and semaglutide together drive record weight loss in global trial A 72 week trial compared the two leading GLP 1 medications in adults with obesity (no diabetes). The results: Tirzepatide: 20.2% weight loss Semaglutide: 13.7% weight loss But weight loss isn't the Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed
Pay in 4 interest-free payments of $6.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14


